Home 5 Lab Industry Report 5 FDA-lir 5 New VALID Act Would Establish Risk-Based System for LDTs Regulation

New VALID Act Would Establish Risk-Based System for LDTs Regulation

by | May 31, 2022

Senate committee members propose a modified version of legislation allowing the FDA to continue to regulate LDTs on a risk-tiered basis.

Senate committee members propose a modified version of legislation allowing the FDA to continue to regulate LDTs on a risk-tiered basis.

This content is Exclusive to Lab Industry Report Subscribers

Subscribe or Log in for Exclusive Access.